Annual Current Liabilities
$8.49 M
-$2.13 M-20.08%
December 31, 2023
Summary
- As of February 8, 2025, ATNM annual total current liabilities is $8.49 million, with the most recent change of -$2.13 million (-20.08%) on December 31, 2023.
- During the last 3 years, ATNM annual current liabilities has risen by +$3.73 million (+78.18%).
- ATNM annual current liabilities is now -20.08% below its all-time high of $10.63 million, reached on December 31, 2022.
Performance
ATNM Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$7.75 M
-$1.97 M-20.28%
September 30, 2024
Summary
- As of February 8, 2025, ATNM quarterly total current liabilities is $7.75 million, with the most recent change of -$1.97 million (-20.28%) on September 30, 2024.
- Over the past year, ATNM quarterly current liabilities has dropped by -$739.00 thousand (-8.70%).
- ATNM quarterly current liabilities is now -61.28% below its all-time high of $20.03 million, reached on March 31, 2014.
Performance
ATNM Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ATNM Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -20.1% | -8.7% |
3 y3 years | +78.2% | +85.1% |
5 y5 years | +40.1% | +40.0% |
ATNM Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -20.1% | +24.2% | -27.0% | +35.5% |
5 y | 5-year | -20.1% | +78.2% | -27.0% | +100.2% |
alltime | all time | -20.1% | >+9999.0% | -61.3% | >+9999.0% |
Actinium Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $7.75 M(-20.3%) |
Jun 2024 | - | $9.73 M(+20.6%) |
Mar 2024 | - | $8.06 M(-5.1%) |
Dec 2023 | $8.49 M(-20.1%) | $8.49 M(-2.1%) |
Sep 2023 | - | $8.67 M(-5.2%) |
Jun 2023 | - | $9.15 M(+16.4%) |
Mar 2023 | - | $7.86 M(-26.0%) |
Dec 2022 | $10.63 M(+55.4%) | $10.63 M(+27.3%) |
Sep 2022 | - | $8.35 M(+32.9%) |
Jun 2022 | - | $6.28 M(+9.8%) |
Mar 2022 | - | $5.72 M(-16.3%) |
Dec 2021 | $6.84 M(+43.5%) | $6.84 M(+63.2%) |
Sep 2021 | - | $4.19 M(+8.2%) |
Jun 2021 | - | $3.87 M(-7.0%) |
Mar 2021 | - | $4.16 M(-12.6%) |
Dec 2020 | $4.77 M(-10.8%) | $4.77 M(+1.9%) |
Sep 2020 | - | $4.68 M(+0.5%) |
Jun 2020 | - | $4.66 M(-1.1%) |
Mar 2020 | - | $4.71 M(-11.9%) |
Dec 2019 | $5.34 M(-11.9%) | $5.34 M(-3.6%) |
Sep 2019 | - | $5.54 M(+7.0%) |
Jun 2019 | - | $5.18 M(-11.6%) |
Mar 2019 | - | $5.85 M(-3.4%) |
Dec 2018 | $6.06 M(+29.9%) | $6.06 M(+47.1%) |
Sep 2018 | - | $4.12 M(-21.7%) |
Jun 2018 | - | $5.27 M(-17.6%) |
Mar 2018 | - | $6.39 M(+37.0%) |
Dec 2017 | $4.67 M(+3.2%) | $4.67 M(+32.2%) |
Sep 2017 | - | $3.53 M(-14.0%) |
Jun 2017 | - | $4.11 M(-23.5%) |
Mar 2017 | - | $5.37 M(+18.8%) |
Dec 2016 | $4.52 M(-2.0%) | $4.52 M(+49.3%) |
Sep 2016 | - | $3.03 M(+21.7%) |
Jun 2016 | - | $2.49 M(-24.3%) |
Mar 2016 | - | $3.29 M(-28.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2015 | $4.61 M(-51.4%) | $4.61 M(+114.1%) |
Sep 2015 | - | $2.16 M(-29.4%) |
Jun 2015 | - | $3.05 M(-15.5%) |
Mar 2015 | - | $3.61 M(-62.0%) |
Dec 2014 | $9.49 M(+29.6%) | $9.49 M(-7.2%) |
Sep 2014 | - | $10.23 M(-8.0%) |
Jun 2014 | - | $11.12 M(-44.5%) |
Mar 2014 | - | $20.03 M(+173.4%) |
Dec 2013 | $7.33 M(+57.8%) | $7.33 M(+112.6%) |
Sep 2013 | - | $3.45 M(-9.8%) |
Jun 2013 | - | $3.82 M(+36.1%) |
Mar 2013 | - | $2.81 M(-39.6%) |
Dec 2012 | $4.64 M(-10.9%) | $4.64 M(>+9900.0%) |
Sep 2012 | - | $31.10 K(+6.5%) |
Jun 2012 | - | $29.20 K(-2.3%) |
Mar 2012 | - | $29.90 K(-99.4%) |
Dec 2011 | $5.21 M(>+9900.0%) | $5.21 M(>+9900.0%) |
Sep 2011 | - | $28.10 K(+14.2%) |
Jun 2011 | - | $24.60 K(-31.5%) |
Mar 2011 | - | $35.90 K(-0.6%) |
Dec 2010 | $36.10 K(+20.7%) | $36.10 K(+10.7%) |
Sep 2010 | - | $32.60 K(-9.7%) |
Jun 2010 | - | $36.10 K(+10.1%) |
Mar 2010 | - | $32.80 K(+9.7%) |
Dec 2009 | $29.90 K(+13.3%) | $29.90 K(+26.7%) |
Sep 2009 | - | $23.60 K(-5.2%) |
Jun 2009 | - | $24.90 K(+16.4%) |
Mar 2009 | - | $21.40 K(-18.9%) |
Dec 2008 | $26.40 K(+190.1%) | $26.40 K(+21.1%) |
Sep 2008 | - | $21.80 K(-6.4%) |
Jun 2008 | - | $23.30 K(+38.7%) |
Mar 2008 | - | $16.80 K(+84.6%) |
Dec 2007 | $9100.00(+106.8%) | $9100.00(+160.0%) |
Sep 2007 | - | $3500.00(+94.4%) |
Jun 2007 | - | $1800.00(-59.1%) |
Dec 2006 | $4400.00 | $4400.00 |
FAQ
- What is Actinium Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals annual current liabilities year-on-year change?
- What is Actinium Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Actinium Pharmaceuticals?
- What is Actinium Pharmaceuticals quarterly current liabilities year-on-year change?
What is Actinium Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ATNM is $8.49 M
What is the all time high annual current liabilities for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high annual total current liabilities is $10.63 M
What is Actinium Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ATNM annual total current liabilities has changed by -$2.13 M (-20.08%)
What is Actinium Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ATNM is $7.75 M
What is the all time high quarterly current liabilities for Actinium Pharmaceuticals?
Actinium Pharmaceuticals all-time high quarterly total current liabilities is $20.03 M
What is Actinium Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ATNM quarterly total current liabilities has changed by -$739.00 K (-8.70%)